HINDI pa rin inirerekomenda ng Department of Health ang paggamit sa antiparasitic drug na Ivermectin bilang panggamot sa COVID-19.
Ito ang muling iginiit ng Department of Health sakabila ng paghikayat ng British Ivermectin Research Development sa Pilipinas na i-adopt na nito ang paggamit sa Ivermectin para sa early treatment ng coronavirus disease.
Ayon kay Health Undersecretary Maria Rosario Vergeire, sinagot na ng DOH ang sulat at sinabi nito na hindi pa rin inirerekomenda ng gobyerno ang nasabing gamot para sa treatment ng COVID-19.
“Based on the current evidence from randomized controlled trials we do not recommend the use of ivermectin for the treatment of COVID-19. It has not proven to significantly reduce mortality, nor to improve other clinical outcomes,” pahayag ni Vergeire.
“Right now the medical consensus is that there is no evidence to support the use of ivermectin in treating COVID-19. While the DOH is not against the use of investigational drugs, we emphasize that in using products under investigation, the safety of every Filipino should take utmost precedence,” dagdag pa nito.
Babaguhin ng departamento ang rekomendasyon sa sandaling magkaroon ng evidence na pwede na itong gamitin base sa isinasagawang ongoing Ivermectin trials.
“We must always put the safety of Filipinos first before showing the use of medicines in the country. So rest assured that the DOH and FDA (Food and Drug Administration) are at the forefront of ensuring COVID-19 drugs and medicines are safe, effective, accessible, and affordable for use,” ayon pa kay Vergeire.
DOH: Ivermectin hindi para sa COVID-19
